Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection

Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection

US Patent 6083503 · Granted Jul 4, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid prote2025
Methods of diagnosing and treating CD55 deficiency, hyperactivation of complemen2024
Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid prote2020
Inhibitors of pre-ligand assembly doman and function of the tumor necrosis facto2015
Function of autophagy genes in cell death2010
Identification of a novel domain in the tumor necrosis factor receptor family th2006
Modified myelin basic protein molecules2006
Nuclear factors associated with transcriptional regulation2002
Applicator system2001
Nuclear factors associated with transcriptional regulation2000
Interleukin-2 stimulated T lymphocyte cell death for the treatment of allergic r1999
Interleukin-4 stimulated T lymphocyte cell death for the treatment of allergic d1999